These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3281595)

  • 21. Efficacy of etretinate for the PUVA-dependent psoriatic.
    Logan RA
    Clin Exp Dermatol; 1987 Mar; 12(2):98-102. PubMed ID: 3677479
    [No Abstract]   [Full Text] [Related]  

  • 22. A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis.
    Parker S; Coburn P; Lawrence C; Marks J; Shuster S
    Br J Dermatol; 1984 Feb; 110(2):215-20. PubMed ID: 6365147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etretinate in pustular psoriasis of palms and soles.
    White SI; Marks JM; Shuster S
    Br J Dermatol; 1985 Nov; 113(5):581-5. PubMed ID: 3904810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PUVA, etretinate, and PUVA-etretinate therapy for pustulosis palmoplantaris. A placebo-controlled comparative trial.
    Rosén K; Mobacken H; Swanbeck G
    Arch Dermatol; 1987 Jul; 123(7):885-9. PubMed ID: 3300565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Etretinate therapy reduces inpatient treatment of psoriasis.
    Ellis CN; Hermann RC; Gorsulowsky DC; Goldfarb MT; Voorhees JJ
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):787-91. PubMed ID: 3680657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatotoxic reactions in a patient treated with etretinate.
    Weiss VC; West DP; Ackerman R; Robinson LA
    Arch Dermatol; 1984 Jan; 120(1):104-6. PubMed ID: 6691707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Rupture of atrophic striae during pustular psoriasis treated with etretinate (Tigason)].
    Bordier C; Flechet ML; Thomine E; Lauret P
    Ann Dermatol Venereol; 1984; 111(10):929-31. PubMed ID: 6098213
    [No Abstract]   [Full Text] [Related]  

  • 28. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of plaque psoriasis with an aromatic retinoid (etretinate)].
    Melis M
    Rev Med Chil; 1984 Jan; 112(1):20-5. PubMed ID: 6377426
    [No Abstract]   [Full Text] [Related]  

  • 30. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term and long-term considerations in the management of psoriasis with retinoids.
    Goldfarb MT; Ellis CN; Voorhees JJ
    Dermatologica; 1987; 175 Suppl 1():100-6. PubMed ID: 3319723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial liver biopsies in psoriatic patients receiving long-term etretinate.
    Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H
    Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Use of etretinate (RO-10-9359) in intermittent doses and follow-up for 1 year in patients with psoriasis. Final report].
    Domínguez Soto L; Hokyo Tomoka MT; Armas JJ
    Med Cutan Ibero Lat Am; 1984; 12(1):47-56. PubMed ID: 6376979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis. Results of a Nordic multicentre study.
    Kragballe K; Jansén CT; Geiger JM; Bjerke JR; Falk ES; Gip L; Hjorth N; Lauharanta J; Mork NJ; Reunala T
    Acta Derm Venereol; 1989; 69(1):35-40. PubMed ID: 2563606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs. etretinate (re-TL-01) vs. etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients.
    Green C; Lakshmipathi T; Johnson BE; Ferguson J
    Br J Dermatol; 1992 Jul; 127(1):5-9. PubMed ID: 1637696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etretinate therapy and thrombocytopenia.
    Naldi L; Rozzoni M; Finazzi G; Pini P; Marchesi L; Cainelli T
    Br J Dermatol; 1991 Apr; 124(4):395. PubMed ID: 2025567
    [No Abstract]   [Full Text] [Related]  

  • 39. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids].
    Gollnick H; Orfanos CE
    Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Etretinate therapy in generalized pustular psoriasis (Zumbusch type). Immediate and long-term results.
    Wolska H; Jabłonska S; Langner A; Fraczykowska M
    Dermatologica; 1985; 171(5):297-304. PubMed ID: 3908171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.